MNKD
Companies
NASDAQ
MannKind Corporation
Health Care
$3.81
-$2.62 (-40.75%)
Price Chart
Overview
About MNKD
mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
Market Cap
$1.3B
Volume
7.6M
Avg. Volume
6.9M
P/E Ratio
25.617647
Dividend Yield
0.00%
Employees
466.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.76
Moderate Correlation
Volatility
High (0.41)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, MNKD shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.3B
Volume7.6M
P/E Ratio25.62
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025